Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) — Capital Reinvestment Ratio
Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) has a Capital Reinvestment Ratio of 0.07x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥415.42 Million) in capital expenditures (CN¥27.09 Million). See how leveraged is Shandong Weigao Orthopaedic Device Co. L's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Weigao Orthopaedic Device Co. Ltd. A Capital Reinvestment Ratio (2019–2025)
This chart tracks Shandong Weigao Orthopaedic Device Co. Ltd. A's Capital Reinvestment Ratio across 7 annual periods. Check how aggressively does Shandong Weigao Orthopaedic Device Co. L reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Weigao Orthopaedic Device Co. Ltd. A (2019–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Weigao Orthopaedic Device Co. Ltd. A from 2019 to 2025. For live market cap and broader valuation context, see market value of Shandong Weigao Orthopaedic Device Co. L.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥415.42 Million | CN¥27.09 Million | ▼ -26.5% |
| 2024 | 0.09x | CN¥274.19 Million | CN¥24.34 Million | ▼ -75.3% |
| 2023 | 0.36x | CN¥119.44 Million | CN¥42.98 Million | ▲ +58.1% |
| 2022 | 0.23x | CN¥508.56 Million | CN¥115.76 Million | ▲ +59.6% |
| 2021 | 0.14x | CN¥788.25 Million | CN¥112.41 Million | ▲ +85.2% |
| 2020 | 0.08x | CN¥644.12 Million | CN¥49.59 Million | ▲ +42.1% |
| 2019 | 0.05x | CN¥534.15 Million | CN¥28.94 Million | — |